XKDCT-080

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameXKDCT-080

Drug Alias Nameanti-guanylyl cyclase C CAR T-cell therapy (Affiliated Hospital of Qingdao University)XKDCT-080

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionHeat-stable enterotoxin receptor modulators

TargetsHeat-stable enterotoxin receptor

Therapy Area/IndicationsSolid tumoursColonic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesThe Affiliated Hospital Of Qingdao University

China Registration ClassN/A

Develop Information

Active CompaniesThe Affiliated Hospital Of Qingdao University

Inactive CompaniesN/A

Active IndicationsSolid tumoursColonic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A